| 12187752 |
Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof |
Christopher J. Burns, Daniel C. Pevear, Luigi XERRI, Timothy Henkel, Daniel McGarry +3 more |
2025-01-07 |
| 11820784 |
Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof |
Christopher J. Burns, Daniel C. Pevear, Luigi XERRI, Timothy Henkel, Daniel McGarry +3 more |
2023-11-21 |
| 11091505 |
Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof |
Christopher J. Burns, Daniel C. Pevear, Luigi XERRI, Timothy Henkel, Daniel McGarry +3 more |
2021-08-17 |
| 6008207 |
Anhydrous alendronate monosodium salt formulations |
Drazen Ostovic, Earl R. Oberholtzer, Jr., J. Eric Thies |
1999-12-28 |
| 5914323 |
Intravenous alendronate formulations |
Musa M. Ghannam |
1999-06-22 |
| 5849726 |
Anhydrous alendronate monosodium salt formulations |
Drazen Ostovic, Earl R. Oberholtzer, Jr., J. Eric Thies |
1998-12-15 |
| 5843924 |
Intravenous alendronate formulations |
Musa M. Ghannam |
1998-12-01 |
| 5780455 |
Intravenous alendronate formulations |
Musa M. Ghannam |
1998-07-14 |
| 5693812 |
Polymorphic forms of an angiotensin II antagonist |
Louis Crocker, Hossain Jahansouz, Robert D. Larsen, Chris Hugh Senanayake, Andrew S. Thompson +2 more |
1997-12-02 |
| 5462932 |
Oral liquid alendronate formulations |
Ashok Katdare, Denise K. Pretzer, Donna T. Whiteford |
1995-10-31 |
| 5356887 |
Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids |
Drazen Ostovich |
1994-10-18 |
| 4190655 |
Amiloride citrate |
Joseph DeMarco |
1980-02-26 |
